Adenocarcinoma of the Pancreas Clinical Trials

61 clinical trials for Adenocarcinoma of the Pancreas across international registries, including 7 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• The HistoSonics Edison™ System for Treatment of Pancreatic Adenocarcinoma Using Histotripsy — RECRUITING · NA
• Neoadjuvant mFOLFIRINOX With Perioperative Oral Hydroxychloroquine in Resectable Pancreatic Adenocarcinoma — RECRUITING · PHASE1
• Resection/Synchronous Pulmonary or Hepatic Oligometastatic Pancreatic Ductal Adenocarcinoma — RECRUITING · NA
• Valproic Acid/Simvastatin Plus Gemcitabine/Nab-paclitaxel Based Regimens in Untreated Metastatic Pancreatic Adenocarcinoma Patients — RECRUITING · PHASE2
• Efficacy and Safety of TPIAT for Resectable Adenocarcinoma of the Pancreas Region at High Risk of Postoperative Fistula — RECRUITING · PHASE1
• Is the 3D-PANC MSP Model Superior to CT for Assessing Response to Neoadjuvant Treatment in PCA Patients? — RECRUITING
• Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma — RECRUITING · PHASE2
• A Phase I/II Trial of TG01 and Gemcitabine as adjuvant therapy for treating patients with pancreatic cancer — COMPLETED · PHASE2
• Switch Maintenance in Pancreatic — SUSPENDED · PHASE1
• FOLFIRINOX With Digoxin in Patients With Resectable Pancreatic Cancer — TERMINATED · PHASE2
• A Study of Neoadjuvant Paricalcitol to Target the Microenvironment in Resectable Pancreatic Cancer — COMPLETED · PHASE1
• Ganitumab in Locally Advanced Unresectable Adenocarcinoma of the Pancreas — TERMINATED · PHASE2
• QUILT-2.019: A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic Cancer — COMPLETED · PHASE1
• QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas — COMPLETED · PHASE3
• Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors — COMPLETED · PHASE1
• Combination Chemotherapy and Radiation Therapy Plus Surgery in Treating Patients With Advanced Cancer of the Pancreas — COMPLETED · PHASE2
• Durvalumab and "Booster" Radiation in Metastatic Adenocarcinoma of the Pancreas — TERMINATED · PHASE2
• Stereotactic Radiation, Nelfinavir Mesylate & Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer — COMPLETED · PHASE1
• Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma — COMPLETED · PHASE2
• Pembrolizumab In Combination With Debio 1143 In Pancreatic and Colorectal Advanced/Metastatic Adenocarcinoma — COMPLETED · PHASE1
• Randomized Trial for Optimal Number of Passes Required for Molecular Profiling During EUS-FNB of Pancreatic Cancer — OTHER · NA
• First-line Treatment of Metastatic Pancreatic Cancer With Nab-paclitaxel and Gemcitabine — COMPLETED · PHASE2
• Dovitinib Lactate, Gemcitabine Hydrochloride, and Capecitabine in Treating Patients With Advanced or Metastatic Solid Tumors, Pancreatic Cancer and Biliary Cancers — COMPLETED · PHASE1
• PEN-866 in Patients With Advanced Solid Malignancies — OTHER · PHASE1
• SBRT for Close or Positive Margins After Resection of Pancreatic Adenocarcinoma — COMPLETED · NA
• Capecitabine, Bevacizumab, and Radiation Therapy Followed By Gemcitabine and Bevacizumab in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery — COMPLETED · PHASE2
• Combination Chemotherapy Plus Radiation Therapy With or Without Tipifarnib in Treating Patients With Locally Advanced Pancreatic Cancer — COMPLETED · PHASE2
• Selumetinib and Erlotinib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer — COMPLETED · PHASE2
• Dose Escalation Trial of AZD1775 and Gemcitabine (+Radiation) for Unresectable Adenocarcinoma of the Pancreas — COMPLETED · PHASE1
• Study To Establish Maximum Tolerated Dose (MTD) of Cyberknife in Patients With Un-Resectable Pancreas Cancer (TL002) — TERMINATED · PHASE1
• Pre-operative Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma With or Without CCX872-B — WITHDRAWN · PHASE1
• Saracatinib in Treating Patients With Previously Treated Metastatic Pancreatic Cancer — COMPLETED · PHASE2
• Study of AUY922 in Metastatic Pancreatic Cancer Who Are Resistant to First Line Chemotherapy — TERMINATED · PHASE2
• Eribulin Mesylate as Second-Line Therapy for Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer Patients — COMPLETED · PHASE2
• Perioperative Therapy for Resectable Pancreatic Cancer — COMPLETED · PHASE2
• Gemcitabine, Bevacizumab and Erlotinib in Pancreatic Cancer — COMPLETED · PHASE2
• Vorinostat With XRT and 5-FU for Locally Advanced Adenocarcinoma of the Pancreas — TERMINATED · PHASE1
• A Study of Pre-Operative Cyberknife in Patients With Potentially Resectable Pancreas Cancer — OTHER · PHASE1
• Phase I Study of Gemcitabine, Sorafenib and Radiotherapy in Patients With Unresectable Pancreatic Cancer — COMPLETED · PHASE1
• Dasatinib in Treating Patients With Metastatic Pancreatic Cancer — COMPLETED · PHASE2
• Gemcitabine Hydrochloride With or Without Bevacizumab in Treating Patients Who Are Undergoing Surgery for Pancreatic Cancer — WITHDRAWN · PHASE2
• Gamma Secretase Inhibitor RO4929097 in Previously Treated Metastatic Pancreas Cancer — COMPLETED · PHASE2
• Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Stage IV Pancreatic Cancer — COMPLETED · PHASE2
• PhII Study STA-9090 as Second or Third-Line Therapy for Metastatic Pancreas Cancer — TERMINATED · PHASE2
• Docetaxel and Flavopiridol in Treating Patients With Refractory Metastatic Pancreatic Cancer — COMPLETED · PHASE2
• Bevacizumab and Gemcitabine Combined With Either Cetuximab or Erlotinib in Treating Patients With Advanced Pancreatic Cancer — COMPLETED · PHASE2
• Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors — TERMINATED · PHASE1
• Sunitinib and Gemcitabine in Treating Patients With Pancreatic Cancer or Other Solid Tumors — COMPLETED · PHASE1
• Gamma-Secretase Inhibitor RO4929097 and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors — COMPLETED · PHASE1
• RO4929097 Before Surgery in Treating Patients With Pancreatic Cancer — TERMINATED · PHASE1

Refine this search